Teva Pharmaceuticals announced in late August 2025 that it received FDA approval and commenced the U.S. launch of its generic version of Saxenda® (liraglutide injection), which had annual sales of ...

Teva Pharmaceuticals has launched the first generic GLP-1 drug for weight loss in adults and adolescents; a lower-cost ...

Teva Pharmaceuticals gained FDA approval to launch the first generic GLP-1 drug for weight loss, a liraglutide injection based on Saxenda.

The Food and Drug Administration is cracking down on ingredients from potentially from unverified foreign sources and that ...

BRITS have been warned about a surge in black market demand for a powerful new drug dubbed the “Godzilla” of fat jabs.

Losing weight can be emotional, but the Cork plant making the active ingredient in weight-loss drug Mounjaro has no room for ...

AS fat jab users panic and race to stock up on Mounjaro, a sharp rise in fake pharmacies will be capitalising on users’ money ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best strong buy growth stocks to buy now. On August 28, Teva Pharmaceutical Industries Limited (NYSE:TEVA) announced the FDA approval ...

The test in my hand seemed like a hallucination. Two little lines telling me I was, without a shadow of a doubt, pregnant.

Israeli drugmaker Teva Pharmaceutical Industries has announced US Food and Drug Administration (FDA) approval and launch of a generic version of Saxenda (liraglutide injection).

IT was the start of a new life when Hope Lancaster Colquhoun lost 9st, having turned to ‘fat jabs’ when her 18st body left ...

More than 1.1 million prescriptions for the weight-loss drugs Saxenda and Wegovy have been issued in South Korea over the ...